Surgical Management of Hepatocellular Carcinoma

0Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.
Get full text

Abstract

It is crucial to tailor the surgical management of hepatocellular carcinoma (HCC) to clinical pictures of end-stage liver disease to avoid dramatic neoplastic progression and negative outcomes. The timing of HCC recognition, its extent, the patient’s condition, and the availability of a referral hepatobiliary center influence the complexity of the treatment and clinical outcomes. It is known, for example, that the best results in terms of prognostic and efficacious treatment are obtained when the HCC lesion is detected early. When HCCs are unfit for liver resection and/or associated with end-stage liver disease (ESLD), a complex clinical condition may require liver transplantation (LT) or possibly even interventional radiological procedures as a neoadjuvant bridging option.

Cite

CITATION STYLE

APA

Pagano, D., Mamone, G., Calamia, S., & Gruttadauria, S. (2022). Surgical Management of Hepatocellular Carcinoma. In Hepato-Pancreato-Biliary Malignancies: Diagnosis and Treatment in the 21st Century (pp. 131–145). Springer International Publishing. https://doi.org/10.1007/978-3-030-41683-6_7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free